Corporate Tech Investors

Astellas Venture Capital

Astellas Venture Capital is a corporate entity that makes strategic investments in companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

Astellas Pharma Inc., the ultimate parent company of AVC headquartered in Tokyo, was created on April 1, 2005, by the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. The new company is the one of the top pharmaceutical companies in Japan in terms of sales, R&D investment and the number of medical representatives.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

2/1/2024

Transaction History

Our records indicate that Astellas Venture Capital invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Investment Director

Hiromichi Kimura

        

President

Shunichiro Matsumoto

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Astellas Venture Capital has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Assure Syndicates | AstraZeneca

Share this article

About Our Database of Corporate Tech Investors

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary